奥卡西泮
医学
焦虑
萧条(经济学)
抗焦虑药
单胺氧化酶
精神科
内科学
药理学
苯二氮卓
生物化学
化学
受体
经济
宏观经济学
酶
作者
Harry R. Bailey,Evan Davies,Ian Morrison
标识
DOI:10.1185/03007998109114256
摘要
SummaryA total of 1600 patients suffering from depression and anxiety was treated in one consultant practice over an 8-year period. In most cases, the depressive component was treated by monoamine oxidase inhibitors, but oxazepam was used as the anxiolytic in all cases in the series. Patients were encouraged to regulate their own dosage of oxazepam, and no difficulties occurred with this technique. The results showed the overall effectiveness of oxazepam as an anxiolytic to be better than 87% in those cases where depression co-existed.
科研通智能强力驱动
Strongly Powered by AbleSci AI